While none have yet received official approval, ongoing clinical trials may pave the way for targeted treatments in the future
Clinical trials so far show that GLP-1s are generally safe and effective for long-term use
Another paper in Ageing Research Reviews found that NAD may replenish NAD levels in aged tissues and exhibit beneficial effects against aging and aging-related diseases
However, their clinical application requires rigorous evaluation of therapeutic efficacy, comprehensive safety profiling, and well-defined patient selection criteria
Semaglutide clears the body relatively quickly (half-life of 7 days), but this 2-3 month window allows full elimination, metabolic stabilization, and confirms you have established a new baseline before fetal development begins
Transparent quality: Third-party tested for potency and purity